Low‐risk HPLLs / ABC score patients with splenic marginal zone lymphoma can be safely managed without treatment: Results from a prospective Spanish study
British Journal of Haematology · 2023
DOI: 10.1111/bjh.18912 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift British Journal of Haematology, 2023. Verfasst von Ana Muntañola und 24 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Universitari Mútua Terrassa, Terrassa, Spain. Hauptthemen laut MEDLINE: Lymphoma, B-Cell, Marginal Zone, Splenic Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
The aims of our study were to analyse compliance with the 2014 GELTAMO SMZL Guidelines, in patients with splenic marginal zone lymphoma (SMZL), and to evaluate the outcome according to the HPLLs/ABC‐adapted therapeutic strategy. Observational prospective multicenter study of 181 SMZL patients diagnosed between 2014 and 2020. Lymphoma‐specific survival (LSS), composite event‐free survival (CEFS) and response rates were assessed. 57% of the 168 patients included in the analysis followed the Guidelines. The overall response rate was higher in the rituximab chemotherapy and in the rituximab arms compared with the splenectomy arm ( p < 0.001). The 5‐year overall survival was 77% and the 5‐year LSS of 93%. There were no differences in the 5‐year LSS according to the treatment received ( p = 0.68). The 5‐year CEFS in the overall series was 45%, and there were significant differences between scores A and B ( p = 0.036). There were no significant differences when comparing LSS and progression‐free survival in patients treated with rituximab or rituximab chemotherapy at diagnosis or after observation. Our data support HPLLs/ABC score as a practical tool for the management of SMZL, observation as the best approach for patients in group A and rituximab as the best treatment for group B.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospital Universitari Mútua Terrassa, Terrassa, Spain.
- Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain.
- Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain.
- Hospital Universitario 12 de Octubre, Madrid, Spain.
- University of Florida Hospital, Jacksonville, Florida, USA.
- Hospital Universitario Fundación Jiménez Díaz, Instituto de Investigación Sanitaria IIS-FDJ, Madrid, Spain.
ORCID-Profile: Ana Muntañola, María Teresa Villalobos, Ana Jiménez-Ubieto, Raúl Córdoba, Juan Manuel Sancho, Pablo Mozas, Armando López-Guillermo, Antonio Salar, Carlos Montalbán
Zitieren
APA
Muntañola, A., Villalobos, M. T., González-Villambrosia, S., Rodríguez-Salazar, M. J., Jiménez-Ubieto, A., Bastidas-Mora, G., Córdoba, R., Infante, M., Vidal, M. J., Díaz, F. J., Baile, M., Bastos-Oreiro, M., Panizo, C., Sancho, J. M., Navarro, B., García, T., Escoda, L., Abrisqueta, P., Terol, M. J., …, & GELTAMO group (Grupo Español de Linfomas y Trasplante de Médula Ósea) (2023). Low‐risk HPLLs / ABC score patients with splenic marginal zone lymphoma can be safely managed without treatment: Results from a prospective Spanish study. British Journal of Haematology. https://doi.org/10.1111/bjh.18912
Vancouver
Muntañola A, Villalobos MT, González-Villambrosia S, Rodríguez-Salazar MJ, Jiménez-Ubieto A, Bastidas-Mora G, et al. Low‐risk HPLLs / ABC score patients with splenic marginal zone lymphoma can be safely managed without treatment: Results from a prospective Spanish study. British Journal of Haematology. 2023. doi:10.1111/bjh.18912
BibTeX
@article{Muntaola2023,
author = {Muntañola, Ana and Villalobos, María Teresa and González-Villambrosia, Sonia and Rodríguez-Salazar, María José and Jiménez-Ubieto, Ana and Bastidas-Mora, Gabriela and Córdoba, Raúl and Infante, María and Vidal, María Jesús and Díaz, Francisco Javier and Baile, Mónica and Bastos-Oreiro, Mariana and Panizo, Carlos and Sancho, Juan Manuel and Navarro, Belén and García, Tomás and Escoda, Lourdes and Abrisqueta, Pau and Terol, María José and de Campo, Raquel and Mozas, Pablo and López-Guillermo, Armando and Salar, Antonio and Montalbán, Carlos and GELTAMO group (Grupo Español de Linfomas y Trasplante de Médula Ósea), GELTAMO group (Grupo Español de Linfomas y Trasplante de Médula Ósea)},
title = {Low‐risk HPLLs / ABC score patients with splenic marginal zone lymphoma can be safely managed without treatment: Results from a prospective Spanish study},
journal = {British Journal of Haematology},
year = {2023},
doi = {10.1111/bjh.18912}
}
EUVIMED